menu
    • menu

    Company profile for Egis Pharmaceuticals PLC

    Egis Pharmaceuticals PLC-PSE
    News
    Agreement for Biosimilar in Key Central & Eastern EU Markets

    12 Nov 2024

    // PRESS RELEASE

    Egis's Celebrates 10-Y Partnership With Kormend Basketball Team

    19 Oct 2024

    // PRESS RELEASE

    Chemistry for Everyone: Cross-Industry Collaboration

    01 Oct 2024

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Egis Pharmaceuticals

    Contact Supplier

    Website

    CPHI Middle east

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    pipeline-prospector-blog/pipeline-prospector-nov-2024-trump-s-hhs-pick-drags-down-jab-makers-stocks-novartis-merck-roche-ink-billion-dollar-deals

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    SERVICES

    Key Products KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Related CompaniesRelated Companies

    About

    Egis is a member of the Servier Group. Egis’ products are manufactured at 3 production sites in Hungary, which are certified by EMA,FDA, ANVISA, PMDA ,KFDA. Egis sells its products under Egis’ brand names in 18 countries. In total, the company’s APIs & finished products reach 100 countries. Egis’ focus lies on treating diseases of cardiovascular & central nervous systems; however, it also provides modern treatment solutions in the fields of diabetology, dermatology & wound care. Our research and development activities focus on high-quality, value-added branded generic products. From 2023, Egis offers its CDMO & CMO services as well.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Egis Pharmaceuticals PLCHungary Flag
    Country
    Country
    Hungary
    Address
    Address
    1106 Budapest, Keresztúri út 30-38
    Telephone
    Telephone
    +36 18035555
    Client Email
    Email
    mailbox@egis.hu
    Client Website
    Website
    https://int.egis.health/home
    Linkedin
    Linkedin
    https://www.linkedin.com/company/egis-pharmaceuticals-plc/
    youtube
    YouTube
    http://www.youtube.com/@EgisPharma-rs6qr
    Twitter
    Twitter
    Contact Info
    Others

    FDFs
    fpd.opr@egis.hu
    APIs
    bulk.opr@egis.hu
    Services:
    pharmaservices@egis.hu

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPHI Middle east

    CPHI Middle east

    Not Confirmed

    envelop Contact Supplier

    CPHI Middle east

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/egis-pharmaceuticals-plc-party-content-59944.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/egis-pharmaceuticals-party-content-11093.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    FDF Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/egis-pharmaceuticals-plc-party-content-64638.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    API Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/egis-pharmaceuticals-plc-party-content-79538.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    APIs Under Development 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/egis-pharmaceuticals-plc-party-content-98253.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Pharma Services

    read-more

      https://www.pharmacompass.com/pdf/party/content/egis-pharmaceuticals-party-content-3618.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/egis-pharmaceuticals-plc-party-content-45225.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Agreement for Biosimilar in Key Central & Eastern EU Markets
    Agreement for Biosimilar in Key Central & Eastern EU Markets

    12 Nov 2024

    // PRESS RELEASE

    https://int.egis.health/a/agreement-for-biosimilar-candidates-in-key-central-and-eastern-european-markets

    PRESS RELEASE
    12 Nov 2024
    Share Share
    Egis's Celebrates 10-Y Partnership With Kormend Basketball Team
    Egis's Celebrates 10-Y Partnership With Kormend Basketball Team

    19 Oct 2024

    // PRESS RELEASE

    https://int.egis.health/a/ten-years-together-egis-pharmaceuticals-plc-remains-the-partner-of-the-kormend-basketball-team

    PRESS RELEASE
    19 Oct 2024
    Share Share
    Chemistry for Everyone: Cross-Industry Collaboration
    Chemistry for Everyone: Cross-Industry Collaboration

    01 Oct 2024

    // PRESS RELEASE

    https://int.egis.health/a/en-bocy2

    PRESS RELEASE
    01 Oct 2024
    Share Share
    Egis' medicines won the Innovation Grand Prize
    Egis' medicines won the Innovation Grand Prize

    26 Mar 2024

    // PRESS RELEASE

    https://int.egis.health/a/egis-medicines-won-the-innovation-grand-prize

    PRESS RELEASE
    26 Mar 2024
    Share Share
    This Year Marks The 110th Anniversary Of Our Company's Foundation
    This Year Marks The 110th Anniversary Of Our Company's Foundation

    09 Jan 2024

    // PRESS RELEASE

    https://int.egis.health/a/this-was-the-year-we-commemorated-the-th-anniversary-of-the-foundation-of-our-company

    PRESS RELEASE
    09 Jan 2024
    Share Share
    Hungarian Pharmaceutical Company Debuts New Services in Barcelona
    Hungarian Pharmaceutical Company Debuts New Services in Barcelona

    25 Oct 2023

    // HUNGARY TODAY

    https://hungarytoday.hu/hungarian-pharmaceutical-company-debuts-new-services-in-barcelona/

    HUNGARY TODAY
    25 Oct 2023
    Share Share

    LISTED APIs

    read-more
    read-more
    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Abemaciclib

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Egis is a member of the Servier Group. Egis’ products are manufactured at 3 production sites in Hungary, which are certified by EMA,FDA, ANVISA, PMDA ,KFDA. Egis sells its products under Egis’ brand names in 18 countries. In total, the company’s APIs & finished products reach 100 countries. Egis’ focus lies on treating diseases of cardiovas...
    Egis is a member of the Servier Group. Egis’ products are manufactured at 3 production sites in Hungary, which are certified by EMA,FDA, ANVISA, PMDA ,KFDA. Egis sells its products under Egis’ brand names in 18 countries. In total, the company’s APIs & finished products reach 100 countries. Egis’ focus lies on treating diseases of cardiovascular & central nervous systems; however, it also provides modern treatment solutions in the fields of diabetology, dermatology & wound care. Our research and development activities focus on high-quality, value-added branded generic products. From 2023, Egis offers its CDMO & CMO services as well.
    Egis Pharmaceuticals

    01

    Abemaciclib

    Hungary
    arrow
    CPHI Middle east
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Egis Pharmaceuticals PLC

    Egis is a member of the Servier Group. Egis’ products are manufactured at 3 production sites in Hungary, which are certified by EMA,FDA, ANVISA, PMDA ,KFDA. Egis sells its products under Egis’ brand names in 18 countries. In total, the company’s APIs & finished products reach 100 countries. Egis’ focus lies on treating diseases of cardiovascular & central nervous systems; however, it also provides modern treatment solutions in the fields of diabetology, dermatology & wound care. Our research and development activities focus on high-quality, value-added branded generic products. From 2023, Egis offers its CDMO & CMO services as well.

    About the Company : Egis is a member of the Servier Group. Egis’ products are manufactured at 3 production sites in Hungary, which are certified by EMA,FDA, ANVISA, PMDA ,KFDA. Egis sells its products under Egisâ...

    Egis Pharmaceuticals

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place